IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.13
+0.24%Leverage
- Debt / equity
- -0.12x
- Net debt / equity
- 0.71x
- Debt / assets
- 0.09x
- Debt / EBITDA
- -0.06x
- Net debt / EBITDA
- 0.32x
Liquidity & coverage
- Current ratio
- 2.00x
- Quick ratio
- 1.98x
- Cash ratio
- 1.73x
- Interest coverage
- -436.03x
- EBITDA / interest
- -477.73x
- Working capital
- $10.3M
Cash & dividend
- FCF / debt
- -11.76x
- Cash flow / debt
- -10.27x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026